1 Wang, D. et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. Jama, doi:10.1001/jama.2020.1585 (2020).
2 Xie, Y., Bowe, B., Maddukuri, G. & Al-Aly, Z. Comparative evaluation of clinical manifestations and risk of death in patients admitted to hospital with covid-19 and seasonal influenza: cohort study. Bmj, doi:http://dx.doi.org/10.1136/bmj.m4677 (2021).
3 NICE. Covid-19 rapid guideline: managing the long-term effects of covid-19. . (2020).
4 NHS England. National guidance for post-covid syndrome assessment clinics. . (2020).
5 Yelin, D. et al. Long-term consequences of COVID-19: research needs. Lancet Infect Dis 20, 1115-1117, doi:10.1016/S1473-3099(20)30701-5 (2020).
6 Meeting the challenge of long COVID. Nat Med 26, 1803, doi:10.1038/s41591-020-01177-6 (2020).
7 Sivan, M. & Taylor, S. NICE guideline on long covid. Bmj 371, m4938, doi:10.1136/bmj.m4938 (2020).
8 Long-term immunological health consequences of COVID-19. British Society for Immunology (2020).
9 Figueroa, J. D. et al. Distinguishing between direct and indirect consequences of covid-19. Bmj 369, m2377, doi:10.1136/bmj.m2377 (2020).
10 Townsend, E. COVID-19 policies in the UK and consequences for mental health. Lancet Psychiatry 7, 1014-1015, doi:10.1016/S2215-0366(20)30457-0 (2020).
11 Knipe, D., Evans, H., Marchant, A., Gunnell, D. & John, A. Mapping population mental health concerns related to COVID-19 and the consequences of physical distancing: a Google trends analysis. Wellcome open research 5, 82, doi:10.12688/wellcomeopenres.15870.2 (2020).
12 Raker, E. J., Zacher, M. & Lowe, S. R. Lessons from Hurricane Katrina for predicting the indirect health consequences of the COVID-19 pandemic. Proceedings of the National Academy of Sciences of the United States of America 117, 12595-12597, doi:10.1073/pnas.2006706117 (2020).
13 Mahase, E. Covid-19: Mental health consequences of pandemic need urgent research, paper advises. Bmj 369, m1515, doi:10.1136/bmj.m1515 (2020).
14 Del Rio, C., Collins, L. F. & Malani, P. Long-term Health Consequences of COVID-19. Jama, doi:10.1001/jama.2020.19719 (2020).
15 Greenhalgh, T., Knight, M., A’Court, C., Buxton, M. & Husain, L. Management of post-acute covid-19 in primary care. Bmj 370, m3026, doi:10.1136/bmj.m3026 (2020).
16 Gorna, R. et al. Long COVID guidelines need to reflect lived experience. Lancet, doi:10.1016/S0140-6736(20)32705-7 (2020).
17 The, L. Facing up to long COVID. Lancet 396, 1861, doi:10.1016/S0140-6736(20)32662-3 (2020).
18 Xie, Y. et al. Proton Pump Inhibitors and Risk of Incident CKD and Progression to ESRD. Journal of the American Society of Nephrology : JASN 27, 3153-3163, doi:10.1681/ASN.2015121377 (2016).
19 Xie, Y. et al. Risk of death among users of Proton Pump Inhibitors: a longitudinal observational cohort study of United States veterans. BMJ Open 7, e015735, doi:10.1136/bmjopen-2016-015735 (2017).
20 Xie, Y. et al. Long-term kidney outcomes among users of proton pump inhibitors without intervening acute kidney injury. Kidney international 91, 1482-1494, doi:10.1016/j.kint.2016.12.021 (2017).
21 Xie, Y. et al. Higher blood urea nitrogen is associated with increased risk of incident diabetes mellitus. Kidney international 93, 741-752, doi:10.1016/j.kint.2017.08.033 (2018).
22 Vincent, B. M., Wiitala, W. L., Burns, J. A., Iwashyna, T. J., Prescott, H. C. Using veterans affairs corporate data warehouse to identify 30-day hospital readmissions. Health Services and Outcomes Research Methodology 18, 143-154 (2018).
23 Kind, A. J. & Buckingham, W. R. Making Neighborhood-Disadvantage Metrics Accessible—The Neighborhood Atlas. New England Journal of Medicine 378, 2456-2458 (2018).
24 Wei, Y. et al. Short term exposure to fine particulate matter and hospital admission risks and costs in the Medicare population: time stratified, case crossover study. Bmj 367, l6258, doi:10.1136/bmj.l6258 (2019).
25 Aubert, C. E. et al. Best Definitions of Multimorbidity to Identify Patients With High Health Care Resource Utilization. Mayo Clin Proc Innov Qual Outcomes 4, 40-49, doi:10.1016/j.mayocpiqo.2019.09.002 (2020).
26 HCUP CCSR. Healthcare cost and utilization project (HCUP). Agency for Healthcare Research and Quality, Rockville, MD.
27 Olvey, E. L., Clauschee, S. & Malone, D. C. Comparison of critical drug-drug interaction listings: the Department of Veterans Affairs medical system and standard reference compendia. Clin Pharmacol Ther 87, 48-51, doi:10.1038/clpt.2009.198 (2010).
28 Greene, M., Steinman, M. A., McNicholl, I. R. & Valcour, V. Polypharmacy, drug-drug interactions, and potentially inappropriate medications in older adults with human immunodeficiency virus infection. Journal of the American Geriatrics Society 62, 447-453, doi:10.1111/jgs.12695 (2014).
29 Xie Y et al. Comparative Effectiveness of SGLT2 Inhibitors, GLP1 Receptor Agonists, DPP4 Inhibitors and Sulfonylureas on Risk of Kidney Outcomes: emulation of a target trial using healthcare databases. Diabetes care, doi:https://doi.org/10.2337/dc20-1890.
30 Thomas, L. E., Li, F. & Pencina, M. J. Overlap Weighting: A Propensity Score Method That Mimics Attributes of a Randomized Clinical Trial. Jama 323, 2417-2418, doi:10.1001/jama.2020.7819 (2020).
31 Li, F., Morgan, K. L. & Zaslavsky, A. M. Balancing Covariates via Propensity Score Weighting. Journal of the American Statistical Association 113, 390-400, doi:10.1080/01621459.2016.1260466 (2018).